Cardiac Surgery in Pregnancy

Öz

Cardiovascular applications during pregnancy can be tolerated among pregnant women. However, about 2-4% of women at gestational age have concomitant heart disease. A few of these patients may undergo corrective surgery. In this state, maternal mortality rates are improved so that the rates will be similar to that of non-pregnant patients undergoing the same treatment. However fetal mortality rates are high (35%). The factors that lead to high fetal mortality are the timing of operation, emergency of the operation and fetal/fetoplacental response towards cardiopulmonary bypass. The adjustment of this response may prevent placental dysfunction and uterin contractions. These contractions are the main reason of hypoxia and acidosis. In this article, cardiovascular applications during pregnacy and the effects of cardiovascular bypass on the mother, fetus and fetoplacental unit have been discussed and also manipulations of these responses whether improved the fetal outcome. As a result, perfusion management and off-pump cardiac surgical techniques during pregnancy have been assessed.

Anahtar Kelimeler

• Cardiac surgery, cardiopulmonary bypass, pregnancy.

Gebelikte Kalp Cerrahisi

Öz

Gebelikteki kardiyovasküler girişimler, sağlıklı kadınlarda tolere edilebilir fakat doğurganlık yaşındaki kadınların %2-4'ünde eşlik eden kalp hastalığı vardır. Bu gruptaki hastaların tedaviye cevap vermeyen bir bölümü cerrahi düzeltmeye maruz kalır. Son zamanlarda, maternal mortalite oranları, hamile olmayan hastalardaki seviyelere benzer şekilde iyileştirilmiştir. Fakat fetal mortalite oranı hala yüksek seviyelerdedir (%35). Yüksek fetal mortalite oranına sebep olan faktörler; operasyonun süresi, operasyonun aciliyeti ve kardiyopulmoner baypasa fetal/fetoplasental cevaptır. Bu cevabın değişimi plasental disfonksiyonu ve uterin kasılmalarını önleyebilir. Bu kasılmalar, hipoksi ve asit zehirlenmesinin temelini oluşturur. Bu yazıda, hamilelikteki kardiyovasküler problemler ve kardiyovasküler baypasın anne, fetüs ve fetoplasental birimdeki etkileri üzerinde durulmuştur. Bu cevapların manüplasyonunun fetal sonlanıma neden olup olmadığına değinilmiştir. Sonuç olarak, perfüzyon yönetimi ve hamilelikte pompasız kardiyak cerrahi tekniklerin yaklaşımları değerlendirilmiştir.

Anahtar Kelimeler

• Kalp cerrahisi, kardiyopulmoner baypas, gebelik.

Kaynakça

1. Khandelwal M, Rasanen J, Ludormirski A, Addonizio P, Reece EA. Evaluation of fetal and uterine hemodynamics du- ring maternal cardiopulmonary bypass. Obstet Gynecol 1996; :667-71. niques. New Jersey: Humana press Inc. 2008: 437-8.
2. Aggarwal N, Suri V, Goyal A, Malhotra S, Manoj R, Dha- liwal RS. Closed mitral valvotomy in pregnancy and labor. Int J Gynaecol Obstet 2005;88:118-21.
3. Silberman S, Fink D, Berko RS, Mendzelevski B, Bitran D. Coronary artery bypass surgery during pregnancy. Eur J Cardiothorac Surg 1996;10:925-6.
4. Do QB, Goyer C, Chavanon O, Couture P, Denault A, Cartier R. Hemodynamic changes during off-pump CABG surgery. Eur J Cardiothorac Surg 2002;21:385-90.
5. Perner A, Jorgensen VL, Poulsen TD, Steinbruchel D, Lar- sen B, Andersen LW. Increased concentrations of L-lactate in the rectal lumen in patients undergoing cardiopulmonary by- pass. Br J Anaesth 2005;95:764-8.
6. Fiore G, Brienza N, Cicala P, Tunzi P, Marraudino N, Sc- hinosa Lde L, Fiore T. Superior mesenteric artery blood flow modifications during off-pump coronary surgery. Ann Thorac Surg 2006;82:62-7. bypass. J Thorac Cardiovasc Surg 2000;120:770-7.
7. Bradley SM, Hanley FL, Duncan BW, Jennings RW, Jester JA, Harrison MR, Verrier ED. Fetal cardiac bypass alters regi- onal blood flows, arterial blood gases, and hemodynamics in sheep. Am J Physiol 1992;263:H919-28.
8. Sabik JF, Heinemann MK, Assad RS, Hanley FL. High-do- se steroids prevent placental dysfunction after fetal cardiac bypass. J Thorac Cardiovasc Surg 1994;107:116-25.

9. Reddy VM, McElhinney DB, Rajasinghe HA, Liddicoat JR, Hendricks-Munoz K, Fineman JR, Hanley FL. Role of the en- dothelium in placental dysfunction after fetal cardiac bypass. J Thorac Cardiovasc Surg 1999;117:343-51.
10. Wilkes BM, Krim E, Mento PF. Evidence for a functional renin-angiotensin system in full-term fetoplacental unit. Am J Physiol 1985;249:E366-73.
11. Iwamoto HS, Rudolph AM. Role of renin-angiotensin sys- tem in response to hemorrhage in fetal sheep. Am J Physiol ;240:H848-54. Hooper SB, Walker DW, Harding R. Oxygen, glucose, and lactate uptake by fetus and placenta during prolonged hy- poxemia. Am J Physiol 1995;268:R303-9.
12. Chambers CE, Clark SL. Cardiac surgery during preg- nancy. Clin Obstet Gynecol 1994;37:316-23.
13. Bernal JM, Miralles PJ. Cardiac surgery with cardio- pulmonary bypass during pregnancy. Obstet Gynecol Surv ;41:1-6. Strickland RA, Oliver WC Jr, Chantigian RC, Ney JA, Daniel- son GK. Anesthesia, cardiopulmonary bypass and the pregnant patient. Mayo Clin Proc 1991;66:411-29.
14. Adzick NS, Harrison MR, Slate RK, Glick PL, Villa RL. Sur- face cooling and rewarming the fetus: a technique for experi- mental fetal cardiac surgery. Surg Forum 1984;35:313-6.
15. Crowther CA, Harding JE. Repeat doses of prenatal cor- ticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev ; (3):CD003935.
16. Mongero LB, Beck JR. On bypass; advanced perfusion tech